134 related articles for article (PubMed ID: 37558641)
1. [A Case of Prostate Cancer Diagnosed by the Bone Biopsy of the Right Iliac Metastatic Lesion].
Konishi M; Okamoto S; Yamamoto T; Kanaki T; Oshima J; Kinjo T; Nakata W; Ohashi H; Inoue H
Hinyokika Kiyo; 2023 Jul; 69(7):193-197. PubMed ID: 37558641
[TBL] [Abstract][Full Text] [Related]
2. A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
Iwamura H; Hatakeyama S; Tanaka Y; Tanaka T; Tokui N; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Ohyama C
BMC Res Notes; 2014 Jan; 7():64. PubMed ID: 24476098
[TBL] [Abstract][Full Text] [Related]
3. [A case of prostate cancer diagnosed pathologically by bone metastatic site biopsy].
Nakata S; Nakano K; Takahashi H; Shimizu K; Higashi H; Ohki K
Nihon Hinyokika Gakkai Zasshi; 2005 May; 96(4):507-10. PubMed ID: 15948412
[TBL] [Abstract][Full Text] [Related]
4. [Prostate cancer diagnosed through the biopsy of the bone metastatic lesion; a case report].
Ueda Y; Higuchii Y; Hashimoto T; Mitsui Y; Maruyamai T; Kondou N; Nojima M; Yamamoto S; Shincho M; Hirota S; Shima H
Hinyokika Kiyo; 2007 May; 53(5):327-30. PubMed ID: 17561720
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. To treat or not to treat, that is the question: the role of bone-targeted therapy in metastatic prostate cancer.
Higano CS
J Clin Oncol; 2014 Apr; 32(11):1107-11. PubMed ID: 24590651
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
8. [A case of prostate cancer diagnosed by lymphadenectomy].
Fukumoto R; Soda T; Uehara M; Hayashi T; Oka D; Fujimoto N; Koide T
Hinyokika Kiyo; 2012 Oct; 58(10):557-60. PubMed ID: 23235279
[TBL] [Abstract][Full Text] [Related]
9. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Prostate Cancer with High Levels of Prostate-Specific Antigen Undetected by Prostate Biopsy].
Shimizu K; Nakano S; Okada Y; Nagahama K; Okubo K; Yasuhara Y
Hinyokika Kiyo; 2019 Mar; 65(3):75-80. PubMed ID: 31067847
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma diagnosed during hormonal therapy for prostate cancer: report of two cases].
Yoshinaga A; Okada Y; Ichiyanagi N; Kamata S
Hinyokika Kiyo; 2012 May; 58(5):243-7. PubMed ID: 22767278
[TBL] [Abstract][Full Text] [Related]
13. [A Case of de novo Neuroendocrine Prostate Cancer].
Kise H; Shiraishi T
Hinyokika Kiyo; 2021 Mar; 67(3):113-118. PubMed ID: 33957032
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
Castellucci P; Fuccio C; Rubello D; Schiavina R; Santi I; Nanni C; Allegri V; Montini GC; Ambrosini V; Boschi S; Martorana G; Marzola MC; Fanti S
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):55-63. PubMed ID: 20848281
[TBL] [Abstract][Full Text] [Related]
15. Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?
Saylor PJ; Michaelson MD
Oncologist; 2012; 17(2):288-90. PubMed ID: 22267850
[TBL] [Abstract][Full Text] [Related]
16. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
[TBL] [Abstract][Full Text] [Related]
17. Association of prostate-specific antigen levels and patterns of benign and malignant uptake detected. on bone scintigraphy in patients with newly diagnosed prostate carcinoma.
Jacobson AF
Nucl Med Commun; 2000 Jul; 21(7):617-22. PubMed ID: 10994663
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate treatment of prostate cancer caused by heterophilic antibody interference.
Henry N; Sebe P; Cussenot O
Nat Clin Pract Urol; 2009 Mar; 6(3):164-7. PubMed ID: 19265858
[TBL] [Abstract][Full Text] [Related]
19. [Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report].
Yamada Y; Fujiwara H; Somiya S; Fujikawa S; Kamiyama Y; Tamaki M; Kanaoka T
Hinyokika Kiyo; 2018 Apr; 64(4):187-192. PubMed ID: 29772622
[TBL] [Abstract][Full Text] [Related]
20. [Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].
Fukushi K; Koie T; Yamamoto H; Okamoto A; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
Hinyokika Kiyo; 2013 Apr; 59(4):247-50. PubMed ID: 23635462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
